Assessment of the matrix degenerative effects of MMP-3, ADAMTS-4, and HTRA1, injected into a bovine intervertebral disc organ culture model by Furtwängler, Tina et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2013
Assessment of the matrix degenerative effects of MMP-3, ADAMTS-4, and
HTRA1, injected into a bovine intervertebral disc organ culture model
Furtwängler, Tina; Chan, Samantha C W; Bahrenberg, Gregor; Richards, Peter; Gantenbein, Benjamin
Abstract: STUDY DESIGN: In vitro study to develop an intervertebral disc degeneration organ culture
model, using coccygeal bovine intervertebral discs (IVDs) and injection of proteolytic enzymes MMP-3,
ADAMTS-4, and HTRA1. OBJECTIVE: This study aimed to develop an in vitro model of enzyme-
mediated intervertebral disc degeneration to mimic the clinical outcome in humans for investigation of
therapeutic treatment options. SUMMARY OF BACKGROUND DATA: Bovine IVDs are comparable
with human IVDs in terms of cell composition and biomechanical behavior. Researchers injected papain
and trypsin into them to create an intervertebral disc degeneration model with a degenerated nucleus
pulposus (NP) area. They achieved macroscopic cavities as well as a loss of glycosaminoglycans (GAGs).
However, none of these enzymes are clinically relevant. METHODS: Bovine IVDs were harvested main-
taining the endplates. Active forms of MMP-3, ADAMTS-4, and HTRA1 were injected at a dose of 10
￿g/mL each. Phosphate-buffered saline was injected as a control. Discs were cultured for 8 days and
loaded diurnally (days 1-4 with ￿0.4 MPa for 16 hr) and left under free swelling condition from days 4 to
8 to avoid expected artifacts because of dehydration of the NP. Outcome parameters included disc height,
metabolic cell activity, DNA content, GAG content, total collagen content, relative gene expression, and
histological investigation. RESULTS: The mean metabolic cell activity was significantly lower in the NP
area of discs injected with ADAMTS-4 than the day 0 control discs. Disc height was decreased after in-
jection with HTRA1 and was significantly correlated with changes in GAG/DNA of the NP tissue. Total
collagen content tended to be lower in groups injected with ADAMTS4 and MMP-3. CONCLUSION:
MMP-3, ADAMTS-4, and HTRA1 provoked neither visible matrix degradation nor major shifts in gene
expression. However, cell activity was significantly reduced and HTRA1 induced loss of disc height that
positively correlated with changes in GAG/DNA content. The use of higher doses of these enzymes or a
combination thereof may, therefore, be necessary to induce disc degeneration.
DOI: 10.1097/BRS.0b013e31829ffde8
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-85242
Accepted Version
Originally published at:
Furtwängler, Tina; Chan, Samantha C W; Bahrenberg, Gregor; Richards, Peter; Gantenbein, Benjamin
(2013). Assessment of the matrix degenerative effects of MMP-3, ADAMTS-4, and HTRA1, injected into
a bovine intervertebral disc organ culture model. Spine, 38(22):E1377-E1387. DOI: 10.1097/BRS.0b013e31829ffde8
Assessment of the Matrix Degenerative Effects of 
MMP-3, ADAMTS-4 and HTRA1 injected into a 
bovine Intervertebral Disc Organ Culture Model 
 
Tina Furtwängler
1
, Samantha C.W. Chan
1
 PhD, Gregor Bahrenberg
2,3
, 
Peter J. Richards
2,3
 PhD, Benjamin Gantenbein-Ritter
1*
 PhD 
 
1 
Institute for Surgical Technology and Biomechanics, University of Bern, Switzerland 
2 
Bone and Stem Cell Research Group, Center for Applied Biotechnology and 
Molecular Medicine (CABMM), University of Zurich, Switzerland 
3 
Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, 
Switzerland 
*Corresponding Author 
Benjamin Gantenbein-Ritter 
University of Bern, Medical Faculty 
Institute for Surgical Technology and Biomechanics 
Tissue & Organ Mechanobiology 
Stauffacherstrasse 78 
3014 Bern 
Switzerland 
Tel: + 41 031 631 5926 
Fax: + 41 031 631 5960 
E-mail: benjamin.gantenbein@istb.unibe.ch 
Acknowledgements We thank Elena Calandriello for assistance with histological 
assays. 
*Title Page
Enzyme-Mediated Intervertebral Disc Degeneration Model 
 
Abstract  1 
Study design. In vitro study to develop an intervertebral disc degeneration (IDD) organ 2 
culture model, using coccygeal bovine intervertebral discs (IVDs) and injection of proteolytic 3 
enzymes MMP-3, ADAMTS-4 and HTRA1. 4 
Objective. This study aimed to develop an in-vitro model of enzyme-mediated IDD to mimic 5 
the clinical outcome in humans for investigation of therapeutic treatment options. 6 
Summary of Background Data. Bovine IVDs are comparable to human IVDs in terms of 7 
cell composition and biomechanical behavior. Researchers injected papain and trypsin into 8 
them to create an IDD model with a degenerated nucleus pulposus (NP) area. They achieved 9 
macroscopic cavities as well as a loss of glycosaminoglycans (GAGs). However, none of 10 
these enzymes are clinically relevant. 11 
Methods. Bovine IVDs were harvested maintaining the endplates. Active forms of MMP-3, 12 
ADAMTS-4 and HTRA1 were injected at a dose of 10µg/ml each. Phosphate buffered saline 13 
(PBS) was injected as a control. Discs were cultured for 8 days and loaded diurnally (day 1 to 14 
day 4 with ~0.4 MPa for 16 h) and left under free swelling condition from day 4 to day 8 to 15 
avoid expected artifacts due to dehydration of the NP. Outcome parameters included disc 16 
height, metabolic cell activity, DNA content, glycosaminoglycan (GAG) content, total 17 
collagen content, relative gene expression and histological investigation. 18 
Results. The mean metabolic cell activity was significantly lower in the NP area of discs 19 
injected with ADAMTS-4 compared to the day 0 control discs. Disc height was decreased 20 
following injection with HTRA1, and was significantly correlated with changes in GAG/DNA 21 
of the NP tissue. Total collagen content tended to be lower in groups injected with 22 
ADAMTS4 and MMP-3. 23 
*Structured Abstract (300 words)
Conclusions. MMP-3, ADAMTS-4 and HTRA1 neither provoked visible matrix degradation 1 
nor major shifts in gene expression. However, cell activity was significantly reduced and 2 
HTRA1 induced loss of disc height which positively correlated with changes in GAG/DNA 3 
content. The use of higher doses of these enzymes or a combination thereof may therefore be 4 
necessary to induce disc degeneration. 5 
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Keypoints 1 
 Injection of ADAMTS-4 resulted in significantly reduced metabolic cell activity in the 2 
NP area after 8 days of diurnally loaded organ culture compared to the day 0 control 3 
group (p=0.0433). 4 
 The change in disc height due to HTRA1injection positively correlated with the 5 
change in GAG/DNA of the NP tissue (rspearman = 1.0, p = 0.0167). 6 
 Total collagen content measured indirectly by hydroxy (HO)-proline content was not 7 
significantly reduced but tended to be lower in groups injected with ADAMTS-4 and 8 
MMP-3. 9 
 GAG/ HO ratio was generally higher in NP (11.32 ± 2.30, PBS control) and lower in 10 
AF tissue (3.45 ± 0.63). No significant changes were found among treatment groups. 11 
 Relative gene expression of anabolic and catabolic genes did not show any significant 12 
changes after 8 days of organ culture. 13 
 Histology of sagittal sections revealed no significant reductions in proteoglycan 14 
content nor collagen content (Masson trichrome, picrosirius red, safranin o/fast green 15 
staining) 16 
 17 
*Key Points (3-5 main points of the article)
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Miniabstract 1 
Three enzymes, MMP-3, ADAMTS-4 and HTRA1 were injected into bovine in vitro organ 2 
culture for 8 days. Metabolic cell activity was significantly reduced in discs injected with 3 
ADAMTS-4. No significant changes were observed in tissue gene expression, collagen 4 
content or morphology although HTRA1 did induce a loss in disc height which positively 5 
correlated with changes in GAG/DNA content. 6 
 7 
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 1 
Introduction 1 
Low back pain (LBP), a common musculoskeletal disorder
1-3
 with a lifetime-prevalence of up 2 
to 84%
4 
causes an enormous economic burden due to activity limitation and work absence.
5
 3 
Lumbar intervertebral disc degeneration (IDD) is highly associated with non-specific LBP.
6
 It 4 
is a multi-causal condition due to aging,
7,8 
genetic components,
9-11
 obesity
12
 and carrying out 5 
identical work or posture almost all day.13 Biomechanical studies showed that complex 6 
loading like asymmetric compression of the intervertebral disc (IVD) has detrimental 7 
effects.
14,15 
One major characteristic of IDD is a predominance of catabolic enzymes over the 8 
main anabolic components, namely type-II collagen and aggrecan. The proteolytic 9 
endopeptidase MMP-3 could be found to induce loss of proteoglycans (PGs) in the aging IVD 10 
of mice.
16
 Higher levels of MMP-3 were found in human degenerated discs, which suggested 11 
that MMP-3 may be involved in IDD.
17
 ADAMTS-4, a metalloproteinase, which cleaves 12 
aggrecan,
18
 is expressed in herniated disc regions, accompanied with a decrease in PGs.
19
 13 
Higher degeneration levels could be correlated with higher amount of ADAMTS-4 in NP and 14 
AF
20
 thus, it plays a major role in IDD.
21 
Furthermore, mRNA and protein levels of the serine 15 
proteinase HTRA1 were shown to be elevated in patients with severe IDD.
22
 It provoked a 16 
significant increase in MMP-1,-3, -13 and ADAMTS-4 and a decrease in aggrecan.  17 
Current treatment options for IDD in the field of tissue engineering aim to repair or to 18 
regenerate the NP by injecting biomaterials
23,24
 seeded with cells
25 
and preconditioned with 19 
growth-factors.
26,27
 Before testing them in vivo it is necessary to test them in vitro in an 20 
animal organ culture model that exhibits similar cell types, extracellular matrix (ECM) 21 
components, biochemical and biomechanical behavior and a degenerated NP area that allows 22 
injection of some biomaterial combined with an intact AF. Existing models of IDD using 23 
bovine explants generate cavities by injection of papain and trypsin.
28-30
 However, these 24 
previously tested enzymes are very general proteases and cleave multiple peptide bindings 25 
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 2 
and are not very specific to the problem of human IDD. Thus, there is a general lack of 1 
knowledge whether more clinical relevant enzymes, such as ADAMTS-4, MMP-3 or HTRA1 2 
would cause a degenerative pattern to a disc tissue if injected into a healthy IVD. 3 
The aim of this study was to develop an animal organ culture model of enzyme-driven 4 
intervertebral disc degeneration that can be used to mimic the clinical outcome of human 5 
IDD. Studies were carried out to determine the effects of a single injection of MMP-3, 6 
ADAMTS-4 or HTRA1, in bovine coccygeal IVDs cultured for 8 days under diurnal loading. 7 
Typical features of IDD observed in this system included decreases in metabolic cell activity, 8 
DNA, glycosaminoglycans (GAG) and collagen content as well as an up-regulation in the 9 
expression of endogenous catabolic genes and a down-regulation in the expression of anabolic 10 
genes. 11 
 12 
Materials and Methods 13 
Disc harvest and injection of selected enzymes. The preparation of intact IVD for organ 14 
culture followed our previously established protocol.
31 
Fresh bovine tails aged between 6 and 15 
9 months obtained from a local abattoir were dissected within 4 hours after slaughter. Five to 16 
six coccygeal bovine IVDs could be harvested per tail. Muscles and tendons were removed 17 
and the IVD was cut 1-2 mm towards the vertebra by hammering on top using a custom-made 18 
industrial blade holder. Hyaline cartilage of the growth plate on the cutting side was removed 19 
until only the bony endplate was exposed. Discs were washed with a jet lavage system 20 
(Zimmer inc., Münsingen, Switzerland) with sterile lactated Ringer's solution for 30 seconds 21 
on each site and an angle of about 60° to allow better diffusion.
32
 In four discs either active 22 
enzymes  or phosphate buffered saline (PBS) as a control has been injected using a 1ml 23 
syringe (BD Luer Lock ™, Franklin Lakes NJ, USA) with a sterile 22-G needle. For MMP-3 24 
(SRP7783, Sigma-Aldrich, Buchs, Switzerland) injections a Hamilton syringe (#1710, 100ml 25 
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 3 
volume; Hamilton, Bonaduz, Switzerland) was used. The aim was to inject as much volume 1 
as possible to compensate for the differences in disc size. The most distal IVD with the 2 
smallest diameter was used as day 0 control. The enzyme concentrations used were chosen 3 
based on the following findings from other researchers. Ishiguro et al. detected a MMP-3 4 
concentration of 11.7 µg/ml in the synovial fluid of osteoarthritis patients.
33
A plasma 5 
concentration of ADAMTS-4 of 100.2 ± 31.6 ng/ml could be found in patients with acute 6 
coronary syndrome.
34 
Tiaden et al. incubated human IVD cells from herniated IVDs for 24 h 7 
in medium supplemented with recombinant HTRA1 at a concentration of 5 µg/ml to 8 
investigate the role of HTRA1 in IVD degeneration.
22
Purified recombinant active HTRA1 9 
(HTRA1∆mac) was produced in Escherichia coli and purified using metal-affinity 10 
chromatography as previously described.
35
 There were five repeats run (N = 5), each with a 11 
freshly harvested bovine tail and the following group assignment for every tail: Group 1: 12 
Injection of MMP-3 (10µg/ml) (Sigma-Aldrich, Buchs, Switzerland), Group 2: Injection of 13 
ADAMTS-4 (10µg/ml) (R&D systems, Oxon, UK), Group 3: Injection of HTRA1 (10µg/ml), 14 
Group 4: Injection of PBS (Control), Group 5: day 0 fresh Control. 15 
 16 
Organ culture, loading equipment and loading regime. The injected discs were placed in 17 
culture chambers, which were specifically designed for a novel type of two degree of freedom 18 
bioreactor.
32
 The chambers consisted of two cylindrical glass parts, the upper one enclosing 19 
the lower one. They are tightly connected to blocks made of polyoxymethylene which carry 20 
serrated titanium plates that are in direct contact with the discs. The chambers were fixed with 21 
a bar construction and filled with High Glucose Dulbecco’s Modified Eagle Medium (HG-22 
DMEM) (Gibco, Invitrogen, Basel, Switzerland) containing 4.5 g/l D-glucose, L-Glutamin, 23 
0.11 g/l pyruvate, 100 U/ml streptomycin and 100 µg/ml penicillin, 5% fetal calf serum (FCS) 24 
and 0.1% amphotericin β (all from Sigma-Aldrich, Buchs, Switzerland). The chambers were 25 
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 4 
placed in the incubator at 37°C and 5% CO2. Medium was replaced every two days. For the 1 
first 24 h, the discs were not loaded to avoid pressing out the enzyme after injection. From 2 
day 1 to day 4 three diurnally loading cycles (with ~0.4MPa for 16h and no load for 8h) have 3 
been applied. For loading plastic boxes filled with lead beads and a total weight of 4kg have 4 
been used. No load has been applied the remaining four cycles until day 8 to avoid expected 5 
artifacts due to dehydration of the NP. The aim was to detect only the effects of enzyme 6 
injection. 7 
 8 
Disc height. The disc height was measured using an analogue caliper, which has been placed 9 
along the midline of the disc for measurement. 10 
 11 
Metabolic cell activity. Metabolic cell activity was measured using the resazurin sodium salt 12 
metabolic cell activity assay (Sigma-Aldrich, Buchs, Switzerland). NP and AF tissue of all 13 
experimental groups were incubated in 500µl of resazurin solution (50µM in HG-DMEM 14 
containing 5%FCS) for 5 hours at 37°C. Fluorescence was measured at an excitation 15 
wavelength of 547nm and emission wavelength of 582nm using a spectramax M5 microplate 16 
reader (Molecular Devices, Sunnyvale, United States). 17 
 18 
Determination of GAG, DNA and Hydroxy (HO)-Proline content. Dried tissue samples 19 
were digested for approximately 16 hours at 60°C using 125µg/ml papain from Papaya latex 20 
(Sigma-Aldrich, Buchs, Switzerland). For GAG content determination 1,9 dimethylmethylene 21 
blue (DMMB) at pH 1.5 and chondroitin sulfate (Sigma-Aldrich) for the standard curve has 22 
been used. Absorbance was measured at 595 nm immediately. The quantity of DNA was 23 
determined using Bisbenzimide (Hoechst 33258 dye). Standards were prepared from calf 24 
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 5 
thymus (Sigma-Aldrich). The plate was read at excitation wavelength of 350 nm and emission 1 
wavelength of 450 nm.  2 
For determination of HO-proline a colorimetric quantitative assay was used. Color reaction 3 
and standards were prepared in duplicates using saturated NaCl, Chloramin T (Sigma-4 
Aldrich) and 4-Dimethylamino-benzaldehyd (DABA) solution (Fluka, Sigma-Aldrich, 5 
Switzerland). Absorbance was read at 560nm. All assays were read using a spectramax M5 6 
microplate reader (Molecular Devices, Sunnyvale, United States). 7 
 8 
Real-time polymerase chain reaction (PCR). NP and AF tissue was pulverized under liquid 9 
nitrogen and total RNA was isolated using TRI REAGENT® (Molecular Research Center, 10 
Cincinnati, MA, USA), GenElute miniprep kit (Sigma-Aldrich, Buchs, Switzerland) and 11 
DNase I (Sigma-Aldrich). To synthesize cDNA by reverse transcription the iScript kit from 12 
Bio-Rad was used. cDNA was diluted with 80µl of 1X tris-ethylenediaminetetraacetic acid 13 
(EDTA)-buffer. A mastermix containing forward and reverse primers of the bovine species of 14 
selected anabolic and catabolic genes and iQ
TM
 SYBR
®
 Green Supermix (Bio-Rad, Cressier, 15 
Switzerland) was used. Real-time PCR was conducted on a real-time PCR detection system 16 
(iQ5 cycler, Bio-Rad) using the following amplification routine: denaturation 95˚C for 3 min, 17 
50 amplification cycles: 95˚C for 10s, 57˚C for 40s, followed by melting curve analysis. As 18 
reference ribosomal 18S has been used. Oligonucleotide primers (all from Microsynth, 19 
Balgach, CH) have been designed with Primer Beacon Designer™ Software (Premier Biosoft 20 
Inc., Palo Alto, CA, USA) using nucleotide sequences taken from the GenBank database. The 21 
primers are listed in Table 1. The cycle number at which increase in fluorescence and 22 
therefore in cDNA appears exponential was measured by setting the threshold to 55 relative 23 
fluorescence units (RFUs). The relative gene expression (2
-∆∆Ct
) was determined by 24 
comparing either ∆Ct of day 0 samples with ∆Ct of the enzyme injected discs of day 8.  25 
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 6 
 1 
Histological evaluation. Discs cut into halves were fixed in 4% formalin for 2 days. Samples 2 
were dehydrated and infiltrated and finally embedded in methyl methacrylate (MMA). 3 
Samples were sectioned into slides of 6µm thickness using a microtome (Microm 4 
International, Waldorf, Germany). Slides were stained with Masson’s Trichrome stain36, 5 
Safranin O/ Fast green and picrosirius stain. The stained slides were mounted in Eukitt™ 6 
(Sigma) and photographed using the bright field modus of the Nikon Eclipse 800 microscope. 7 
 8 
Statistics. Mean values ± the standard error of the mean (SEM) were calculated. Prism 6, 9 
GraphPad Software, Inc., v6.0b has been used for statistical analysis. For statistical analysis, 10 
the non-parametric Kruskal-Wallis-test was used and Dunn’s test for post-hoc pairwise 11 
comparisons. Spearman’s rank correlation coefficient was used to compare changes in disk 12 
height and GAG/DNA content. A significance value of p < 0.05 was specified. 13 
 14 
 15 
Results  16 
Disc height versus GAG content 17 
The change in disc height due to HTRA1injection positively correlated with the change in 18 
GAG/DNA of the NP tissue (rspearman = 1.0, p = 0.0167, Figure 1). These results suggest that 19 
HTRA1 may contribute to decreases in disc height under pathological conditions and may 20 
subsequently provoke additional features of IDD. 21 
 22 
Metabolic cell activity. Metabolic cell activity was expressed as relative fluorescent units 23 
(RFUs) and normalized to the dry weight of the tissue. A significantly lower metabolic cell 24 
activity was observed in the ADAMTS-4 injected group as compared to the Control group at 25 
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 7 
day 0 (p = 0.0433, Figure 2). ADAMTS-4 was therefore assumed to be a suitable enzyme to 1 
mimic IDD in the described experimental setup. In general, metabolic cell activity was higher 2 
for day 0 samples than for day 8 samples (Figure 2). This difference was also statistically 3 
significant in the AF for the pairing of MMP-3 versus d0 (p = 0.0079) and HTRA1 versus d0 4 
(p = 0.0394).  5 
 6 
DNA, GAG and HO-Proline content. The mean DNA content in the NP tissue was higher 7 
for the day 0 group than the four groups cultured for 8 days (Figure 3). Discs injected with 8 
HTRA1 and the PBS Control group showed the lowest values, although were not significantly 9 
reduced. The values in AF tissue were similar in all groups. None of the groups showed 10 
significantly different DNA content. The mean change in GAG content normalized to DNA is 11 
shown in Figure 4. The mean GAG content tended to be higher after culture in NP tissue in all 12 
groups. The values for NP tissue were highest for the PBS control, followed by HTRA1, 13 
ADAMTS-4 and MMP-3. The HO-proline content tended to be decreased in ADAMTS-4 and 14 
MMP-3 (Figure 5). However, no significant differences were attained between treatment 15 
groups, also with respect to GAG/HO-Proline ratio (Figure 6).  16 
 17 
Relative gene expression. Comparison of groups injected with enzymes to the PBS control 18 
group revealed a higher expression of anabolic genes, i.e. ACAN and type-II collagen in the 19 
NP and AF of enzyme-injected discs (Figure 7). Interestingly, gene expression of the two 20 
catabolic enzymes ADAMTS-4 and MMP-13 was found to be up-regulated by about 10,000 21 
times in the NP and these were found down-regulated in the annulus fibrosus tissue relative to 22 
PBS control. Expression levels of RNA of inhibitors of metalloproteinases, TIMP-1 and 23 
TIMP-3 remained unchanged from level of the PBS control and day 0 control (day 0 data not 24 
shown). MMP-3 did not show major deviations from the baseline (Figure 7).  25 
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 8 
 1 
Histological evaluation. No striking differences in stained components could be observed in 2 
any of the cultured samples at day 0 to day 8 (Figure 8). Injection of ECM degenerating 3 
enzymes did not lead to the expected pattern of disc degeneration, and did not induce any 4 
major structural changes at the cellular level (data not shown). However, a decrease in 5 
proteoglycans was noted in the nucleus pulposus area following treatment with ADAMTS-4 6 
(Figure 8). 7 
 8 
Discussion 9 
IVD Organ Culture Study 10 
The aim of this study was to develop an in vitro bovine organ culture model of IDD by 11 
injecting a subset of catabolic proteases with the intention of mimicking the clinical outcome 12 
of human IDD. Here, we focused on three selected enzymes representing two out of four 13 
major classes of proteases, i.e. MMP-3, ADAMTS-4 (both belonging to the family of MMPs) 14 
and HTRA1 (a representative of the serine proteases, Figure 9).
37
 15 
Decrease of disc height due to a loss in GAG content is a typical feature of IDD.
38,39
 In this 16 
study, the change in disc height of the group injected with HTRA1 in fact showed positive 17 
correlation to the change in GAG content, which leads to the assumption that HTRA1 could 18 
have degenerative potential, which is supported by previous findings from studies carried out 19 
by the authors where HTRA1 was demonstrated as being upregulated in degenerated IVDs 20 
from human patients.
22
. 21 
The effect of external loading is an important feature of the study design to consider. The 22 
human IVD is exposed to certain loads, such as static or dynamic axial compression and 23 
torsion. Complex loading, for example bending combined with compression, as well as 24 
overload or immobilization
40
 can result in disc damage. However, there is a physiological 25 
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 9 
load ranging from 0.1MPa to ~2 MPa
41
 in which dynamic compression facilitates nutrition 1 
and waste exchange.
42
 This means that IVDs require a certain physiological amount of load 2 
both in vivo and in vitro. The load of 0.4 MPa applied diurnally for three cycles in this study 3 
is comparable to the load applied in other studies but is still far from the range that is thought 4 
to cause degeneration. A study which investigated the influence of targeted trypsin injection 5 
and 16 hours compression loading on magnetic resonance (MR) parameters, mechanical and 6 
biomechanical parameters of bovine disc segment showed that only loading had a significant 7 
effect on the MR parameters and biochemical composition in terms of IDD whereas trypsin 8 
had a larger effect on the mechanical properties.
43
 However, the detrimental role of the 9 
loading pattern should be investigated in further studies. 10 
In the current study, the metabolic cell activity in NP tissue was significantly lower in discs 11 
injected with ADAMTS-4 compared to d0 control. This result suggested that injection of 12 
ADAMTS-4 at a concentration of 10µg/ml may lower the cell proliferation and viability in 13 
the described experimental setup and therefore may represent a suitable tool for an in vitro 14 
animal IDD model. Certainly, reduced cell viability has previously been reported in whole 15 
bovine or rabbit IVD organ cultures cultured under degenerative conditions.
44-46
 The bovine 16 
coccygeal IVD is considered to be the most appropriate tissue to mimic the conditions in the 17 
human IVD and as such, has been used several times for characterization and investigation of 18 
an organ culture model.
45,47-52
 However, studies that focus on simulation of IDD using bovine 19 
discs are rare. To the authors’ knowledge, the present study is the first to use injections of 20 
recombinant human MMP-3, ADAMTS-4 and HTRA1 to develop an enzyme-based disc 21 
degeneration model using the bovine IVD. The current study can be compared with other 22 
organ culture models using more catabolic proteolytic enzymes like papain and trypsin. 23 
Several studies using those enzymes either with or without load revealed more explicit results 24 
in terms of detection of macroscopic cavities after injection. Compressive mechanical loading 25 
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 10 
even accelerated loss of proteoglycans, water content and mechanical properties in much 1 
shorter incubation times (around 24-48h).
28,43,53
 A short overview of current studies using 2 
trypsin and/or papain (a cysteine protease, Figure 9) to simulate IDD is given in Table 2. 3 
Trypsin and papain being non-specific in terms of peptide recognition sites and also being 4 
responsible for major GAG loss over a short period of time, however, does not attack cell 5 
viability of remaining cells,
29,53
 which is surprising but also interesting for the application of 6 
testing hydrogels for the IVD repair.
30
 Comparing papain with trypsin, trypsin has to be 7 
considered less standardized since it represents a mixture of at least three trypsins and thus, is 8 
difficult to dose or compare between different products and batches. Furthermore, comparing 9 
the macroscopic changes of the investigated three clinically relevant enzymes with the 10 
cysteine-dependent proteinase papain there was no real cavity visible using sagittal cuts. 11 
Thus, papain produces a highly consistent and reproducible space for injection of biomaterials 12 
and seems to act specifically on GAG-rich tissue (Figure 10).28,29 13 
 14 
Molecular structure and catabolic actions of the three investigated enzymes 15 
MMPs are endopeptidases that play an essential role in various physiological and pathological 16 
processes such as angiogenesis, morphogenesis,
54
 tissue repair, tumor metastasis, tumor 17 
invasion, and inflammatory diseases. MMPs are a family of zinc-containing and zinc 18 
dependent enzymes that have the ability to breakdown connective tissue by hydrolyzing 19 
components of the ECM.
55
 This is important in the process of tissue resorption and the release 20 
of biologically active molecules. Most of the MMPs are composed of a propeptide domain 21 
that contains a cysteine switch motif with a sulfhydryl group,56 a catalytic domain, which 22 
contains three conserved histidines, which ligate the active site Zn
2+
, a proline-rich linker 23 
region and a hemopexin-like C-terminal domain (Figure 9). Most MMPs are secreted as 24 
inactive pro-enzymes (zymogens). The cysteine thiol and zinc ion interaction keeps proMMPs 25 
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 11 
in a latent state. This linkage must be disrupted to activate the enzyme.
57
 The exact in vivo 1 
mechanism of activation of proMMPs is not yet known. Further, all MMPs (except MMP-23) 2 
have a signal peptide to function in the extracellular space.
58
 In our, study we made sure that 3 
all enzymes were already in the activated state as we obtained them from the manufacturers to 4 
exclude uncertainty from activation procedure using mercury-containing compounds, such as 5 
4-Amino-Phenyl-Mercuric Acetate (APMA). 6 
The ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs) family 7 
belongs to the superfamily of metalloproteinases and includes 19 members. ADAMTS-4 8 
(synonym aggrecanase-1) is a secreted multidomain metalloproteinase (Figure 9),
59
 which 9 
cleaves aggrecan at four sites within the chondroitin-sulfate rich region of the aggrecan core 10 
protein. The prodomain is essential for proper folding. It impedes substrate access by its 11 
proximity to the catalytic pocket and its excision is a prerequisite for ADAMTS-4 activity 12 
(Figure 9).
60
 The catalytic domain contains the active site, the catalytic zinc essential for 13 
hydrolysis and two calcium-binding sites. The active site has a dynamic nature with two 14 
different conformations depending on the presence of a ligand. Concerning the disintegrin-15 
like domain (Dis) up to now there is no evidence that it binds integrin but very likely it also 16 
regulates the enzyme activity. The ancillary domains are the central thrombospondin domain 17 
(TS), the cysteine-rich domain (CysR) and the spacer domain (Figure 9).
60
  18 
In humans, the high temperature requirement (HTRA) serine protease family consists of four 19 
members termed HTRA1, -2, -3 and -4.
61
In addition to its involvement in tumor suppression, 20 
HTRA1 may also play a role in cartilage, joint and IVD degeneration due to its ability to 21 
upregulate MMP expression through the generation of fibronectin fragments. 22,62 It has also 22 
been speculated that HTRA1 may influence the development and maintenance of other 23 
musculoskeletal tissues including muscle and bone.
63,64
 24 
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 12 
Inhibition of MMPs 1 
The catalytic activity of MMPs is regulated at four points: First, at the level of transcription 2 
and thus the gene expression. Secondly, growth factors and cytokines play a role. It could be 3 
shown that TNF-α and to an even higher extend IL-1β up-regulates MMP-3, -9 and -13. 65The 4 
third point for regulation is the pro-enzyme activation through the interaction with ECM 5 
components.
54
 In vivo they are activated by tissue or plasma proteinases. In vitro e.g. 6 
mercurial compounds such as APMA) are used to activate the enzymes. A fourth aspect is the 7 
inactivation of enzymes, which means inhibition by endogenous inhibitors. Such inhibitors 8 
are called Tissue Inhibitors of Metalloproteinases (TIMPs). There are currently four known 9 
TIMPs (TIMP-1, TIMP-2, TIMP-3 and TIMP-4) in humans, which bind tightly to the 10 
catalytic side of most metalloproteinases in a 1:1 stoichiometry. TIMP-1 and TIMP-2 are able 11 
to inhibit all MMPs. In particular, TIMP-1 forms a complex with the catalytic domain of 12 
MMP-3. However, the gene expression level of our study indicated no change during the 13 
culture time fort he TIMPs but a strong upregulation of mRNA of MMP-13 and ADAMTS-4 14 
(Figure 7). 15 
 16 
Doses of enzymes detected in human pathological state 17 
Which doses of exogenous enzymes are meaningful to induce disc degeneration in an organ 18 
culture model? Here, we relied on evidence of osteoarthritic research. Examples for the 19 
concentration of MMP-3 in the blood serum level of patients suffering from anti-neutrophil 20 
cytoplasmic antibodies-associated vasculitis or oral lichen planus ranged from 21.6 to 99.6 21 
ng/ml. The secreted MMP-3 level in the supernatants from IVD cells treated with HTRA1 22 
was even lower. Nevertheless, later MMP-3 concentration selection based on the findings of 23 
Nemoto et al.
17
who found concentrations of 0.57 µg/ml/mg wet weight MMP-3 released in 24 
the medium of human IVD explant culture and Ishiguro et al.
33
detected concentration of 11.7 25 
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 13 
µg/ml in synovial fluid of osteoarthritic patients. Only very few information could be found 1 
on typical concentrations of ADAMTS-4. From patients with acute coronary syndrome a 2 
concentration of 100.2ng/ml ± 31.6 ADAMTS-4 was measured in the plasma.
34
 The decision 3 
for the final test concentration of HTRA1 was mainly based on the work of Tiaden et al.
22
 4 
who incubated human IVD cells from herniated IVDs for 24 hours in medium supplemented 5 
with recombinant HTRA1 at a concentration of 5µg/ml to investigate the role of HTRA1 in 6 
IVD degeneration. The results described herein, lead to the conclusion that none of the 7 
investigated enzymes at this dosage, are capable of inducing profound changes in the disc 8 
ECM. Consequently, we may have to consider increased doses, and/or combinations of these 9 
selected enzymes in future studies. However, we also injected a 100 µg of HTRA1 (~ 100-10 
1,000 times more than physiologically measured in synovial fluid) under free-swelling to 11 
exclude artifacts from loading. However, even with this high concentration and in the absence 12 
of loading, we could not detect any striking changes happening to the ECM (data not shown).  13 
 14 
Conclusion 15 
It was the aim of this study to assess the degenerative effects of matrix degrading enzymes but 16 
also to comprise their clinical relevance. Although, clinical relevant MMP-3, ADAMTS-4 and 17 
HTRA1 showed some promising effects, the use of higher doses of these enzymes or a 18 
combination thereof may be necessary to induce disc degeneration. Considering the balance 19 
between costs per unit or per µg of enzyme, it is a consequence that the proteinases papain or 20 
trypsin are much more catabolic (Figure 10) and much cheaper per i.U. cysteine. Therefore, 21 
higher concentrations of papain and trypsin can be applied easily for a disc degeneration 22 
model and make them more appealing than the injection of excess MMP-3, ADAMTS-4 or 23 
HTRA1 although not mimicking the clinical situation. 24 
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List of Tables 1 
Table 1: Bovine specific primers (Bos taurus) for real time RT-PCR using the SYBR green system. 2 
All PCR reactions were run in 2-step protocol (95° for 15s and 57°C for 40s) for 50 cycles. 3 
Gene Common gene name Primer for Primer rev 
Bt_18S 
Bovine reference gene  ACG GAC AGG ATT GAC 
AGA TTG 
CCA GAG TCT CGT TCG 
TTA TCG 
Bt_Col1A2 
Collagen1 A2 GCC TCG CTC ACC AAC TTC AGT AAC CAC TGC TCC 
ATT CTG 
Bt_Col 2 
Collagen 2 CGG GTG AAC GTG GAG 
AGA CA 
GTC CAG GGT TGC CAT 
TGG AG 
Bt_ACAN 
Aggrecan core protein GGC ATC GTG TTC CAT TAC 
AG 
ACT CGT CCT TGT CTC 
CAT AG 
Bt_IL1b Interleukin 1 beta 
AGTGCCATCCTTCTGTCA CATTGCCTTCTCCGCTATT 
Bt_IL-6 
Interleukin 6 (interferon, beta 
2) 
GACTACTTCTGACCACTC ATTCTTCTCACATATCTCC
TT 
Bt_VCAN 
Versican CTGGAGAAGATTGTGTTG GTGTAGGTGAGATGGTAA 
Bt TIMP-1 
Tissue inhibitor of 
metalloproteinases_1 
CAACTCCGATGTCGTCAT TCTCATAACGCTGGTATAA
GG 
Bt TIMP-2 
Tissue inhibitor of 
metalloproteinases_2 
TTGGAGGAAAGAAGGAGTA CACGATGAAGTCACAGAG 
Bt TIMP-3 
Tissue inhibitor of 
metalloproteinases_3 
CAGCAGATAGACTCAAGGT GACACAGACAGACACAGT 
Bt_MMP3 
Matrix metalloproteinase 3 CTT CCG ATT CTG CTG TTG 
CTA TG 
ATG GTG TCT TCC TTG 
TCC CTT G 
Bt_MMP13 
Matrix metalloproteinase 13 TCC TGG CTG GCT TCC TCT 
TC 
CCT CGG ACA AGT CTT 
CAG AAT CTC 
Bt-ADAMTS-4 
A disintegrin and 
metalloproteinase with 
thrombospondin motifs-4 
TCC TGG CTG GCT TCC TCT 
TC 
CCT CGG ACA AGT CTT 
CAG AAT CTC 
 4 
Tables
Table 2: Recent studies using Trypsin and/or Papain for organ culture model. 1 
Reference Injected Enzyme Load Duration Main Results 
Jim et al.
53
 Trypsin: 2.5g/50µl 
PBS 
No 4 weeks 60% Loss of proteoglycans after 7 days 
Roberts et 
al.
28
 
Papain: 20mg/ml 
Trypsin: 1,5,10,20 
mg/ml 
No 2 weeks Discs were macro- and microscopically 
fragmented, severe metachromasia, 
macroscopic cavities and 20% loss of 
proteoglycans after 2 weeks. 
Chan et al.
29
 Papain: 
3,15,30,60,150 
U/ml 
No 10 days Macroscopic cavity for 30U/ml and higher 
GAGs completely lost for 15U/ml and 
higher (less than 10% left in NP area), 
drop in compressive and rotational 
stiffness, loss of water content for 60U/ml 
and higher 
Mwale et 
al.
43
 
Trypsin: 5 mg Yes, 
1 Hz, 
16 h 
16 hours Effect of loading was greater on MR 
parameters and biochemical composition 
typical for IDD 
Trypsin had larger effect on mechanical 
properties 
  2 
 3 
 4 
Enzyme-Mediated Intervertebral Disc Degeneration Model 
 
Figure Legends 1 
 2 
Figure 1. Change in disc height compared to change in GAG content in NP tissue of bovine 3 
disc explants injected with HTRA1 at day 0 and after 8 days of diurnal loaded organ culture. 4 
A significant positive correlation could be detected using Spearman correlation test and 5 
including the measurements of the first main experiment (rspearman=1.0, p=0.0167, N = 5). 6 
 7 
Figure 2. Mean metabolic cell activity in RFU/ µg dry weight (mean ± SEM, N = 5) of 8 
bovine IVD explants at day 0 and after 8 days of diurnal loaded organ culture. Significant 9 
differences could be found in NP: ADAMTS-4 vs. d0 (P = 0.0433) and AF: MMP-3 vs. d0 (P 10 
=0.0079) and HTRA1 vs. d0 (P = 0.0394), * = P < 0.05, ** 0.001<P < 0.01.  11 
 12 
Figure 3. Mean DNA content/ dry weight
 
of bovine IVD organ culture with injected enzymes 13 
(mean ± SEM, N = 5) at day 0 and after 8 days of culture. Although the value for day 0 14 
Control group in NP tissue is higher than in all cultured groups, no significant differences 15 
amongst the five groups could be found. 16 
 17 
Figure 4. Mean GAG/DNA ratio of bovine IVD organ culture with injected enzymes (mean ± 18 
SEM, N = 5) at day 0 and after 8 days of culture.  19 
 20 
 Figure 5. HO-Proline content per dry weight tissue bovine IVD organ culture with injected 21 
enzymes (mean ± SEM, N = 5) at day 0 and after 8 days of culture, NP: nucleus pulposus, 22 
AF: annulus fibrosus. 23 
 24 
Figure Legends
Figure 6. GAG / HO-Proline ratio of bovine IVD organ culture with injected enzymes (mean 1 
± SEM, N = 5) at day 0 and after 8 days of culture. * = P < 0.05.  2 
 3 
Figure 7. Relative gene expression (2
-∆∆Ct
 method) in NP and AF tissue of bovine IVD organ 4 
culture with injected enzymes relative to PBS control after 8 days of culture (N = 5, mean ± 5 
SEM).  6 
 7 
Figure 8. Histological sagittal sections of bovine IVD organ culture with injected enzymes on 8 
day 0 and after 8 days of culture. Left column: Masson’s trichrome, middle column: 9 
Pircosirius red, right column: Safranin O/Fast Green.  10 
 11 
Figure 9. 1. Overview of classification families of proteases according to Horn (2009)37 2. 12 
General domain arrangement of vertebrate MMPs after Nagase et al. (1999)
54
 and Parks et al. 13 
(1998).
58
 14 
 15 
Figure 10. Macroscopic sagittal view of bovine coccygeal IVDs cut with a a guillotine-like 16 
cutter tool after 8 days of organ culture injected either with phosphate buffered saline (PBS) 17 
control or with one of three catabolic enzymes MMP-3, ADAMTS-4 and HTRA1 18 
(concentration of ~1 µg/ disc) compared to the cysteine-dependent proteinase papain with 30 19 
U/disc.
29
 The arrow denotes the cavity, created after 48h of incubation with 30 U of injected 20 
papain. 21 
 22 
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